UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 14, 2020
Accession Number:
Submission Type:
CIK: 0001764013
Company Name: Immunovant, Inc.
File Number: 333-237627